Refine Results
- Applications and Industries
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Applied Filters
Aggregate analysis of adeno-associated viruses with AdvanceBio SEC 500 Å columns
- Publication Part Number: 5994-7509EN
- Created: 28 May 2024
- 729 KB
Aggregate analysis of a ~50 nm virus-like particle using an AdvanceBio SEC 1000Å column.
- Publication Part Number: 5994-7427EN
- Created: 22 May 2024
- 330 KB
The enzyme l-asparaginase poses a challenge for quantifying aggregation as its structure may produce high molecular weight aggregates.
- Publication Part Number: 5994-6587EN
- Created: 28 July 2023
- 543 KB
必威体育登录手机An SEC method identifying innovator and biosimilar insulin analog was developed using an Agilent AdvanceBio SEC 130Å, 7.8 × 300 mm, 2.7 μm column.
- Publication Part Number: 5991-6872EN
- Created: 12 May 2021
- 513 KB
Evaluation of SEC Columns for Analysis of ADC Aggregates and Fragments - Choosing the best stationary phase to overcome nonspecific interactions.
- Publication Part Number: 5994-3276EN
- Created: 11 May 2021
- 376 KB
必威体育登录手机This collection of 10 Agilent ‘aggregate and fragment analysis' app notes also includes our guide on how to perform SEC for biomolecule analysis.
- Publication Part Number: 5994-0032EN
- Created: 01 Apr 2021
- 7 MB
必威体育登录手机An overview of the separation and characterization of Emicizumab, using a variety of products from the Agilent biocolumns portfolio.
- Publication Part Number: 5994-2997EN
- Created: 03 Mar 2021
- 703 KB
In this application note, we have developed a mass spectrometry-compatible, native-mode size exclusion (SEC/MS) method for characterization of a challenging FDC with very low pI.
- Publication Part Number: 5994-3045EN
- Created: 09 Feb 2021
- 1 MB
Nanobody analysis with AdvanceBio SEC 120 Å 1.9 μm column for size exclusion chromatography and AdvanceBio HIC column hydrophobic interaction chromatography (HIC)
- Publication Part Number: 5994-1869EN
- Created: 15 Apr 2020
- 3 MB
Comparison of AdvanceBio SEC 200 Å 1.9 µm column for SEC analysis of hGH, hG-CSF and IFN alpha-2b therapeutic proteins with sub-2 µm particle columns from other vendors.
- Publication Part Number: 5994-1829EN
- Created: 30 Mar 2020
- 516 KB
必威体育登录手机Presents a method for the rapid analysis of a monoclonal antibody using the Agilent AdvanceBio SEC 200 Å 19 µm column.
- Publication Part Number: 5994-0828EN
- Created: 27 Mar 2020
- 414 KB
Comparison of HPLC method and a quick method developed using the Cary 60 UV-Vis
- Publication Part Number: 5991-7974EN
- Created: 13 Mar 2020
- 413 KB
This application note describes a robust LC/MS method for the analysis of native protein analysis.
- Publication Part Number: 5994-1739EN
- Created: 12 Mar 2020
- 948 KB
Improvements in resolution and shorter run times using AdvanceBio SEC 120 Å 1.9 μm, 4.6 x 300 mm column for insulin analysis.
- Publication Part Number: 5994-1566EN
- Created: 06 Feb 2020
- 319 KB
必威体育登录手机Size Exclusion Chromatography Method Development of NIST mAb Using an Agilent AdvanceBio SEC 200 Å, 1.9 µm Column
- Publication Part Number: 5994-0876EN
- Created: 17 Apr 2019
- 809 KB
必威体育登录手机Describes a comparison between the Agilent AdvanceBio SEC 200 Å 1.9 µm column and other vendors' SEC columns in terms of mAb and ADC analysis.
- Publication Part Number: 5994-0827EN
- Created: 08 Apr 2019
- 756 KB
Size exclusion chromatography with light scattering detection was used to investigate the impact of varying SDS concentration on protein molecules.
- Publication Part Number: 5991-7989EN
- Created: 22 Nov 2017
- 1 MB
必威体育登录手机The Agilent AdvanceBio SEC column together with the Agilent 1260 Infinity II Bio-inert System is an ideal combination for the aggregate analysis of ADCs
- Publication Part Number: 5991-8244EN
- Created: 30 June 2017
- 752 KB
An aggregate analysis workflow for SEC mobile phase optimization and characterization of mAb aggregation profiles
- Publication Part Number: 5991-7476EN
- Created: 04 Nov 2016
- 544 KB
"This Application Note describes the quantification of aggregates in biotherapeutic
- Publication Part Number: 5991-7223EN
- Created: 01 Sep 2016
- 598 KB